NCT06640309View on ClinicalTrials.gov

The Effect of Nicotinamide on the Clinical Outcome of Rheumatoid Arthritis Patients

PHASE2RecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

December 2, 2023

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Nicotinamide Tablet

Nicotinamide is anti-inflammatory and antioxidant.

DRUG

conventional synthetic antirheumatic drugs

methotrexate- leflunomide- sulfasalazine- hydroxychloroquine

Trial Locations (1)

Unknown

RECRUITING

Ain Shams University Hospitals, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER